Prognosis of vasculitis associated myelodysplasia

Autoimmunity Reviews

Volumn 12, Issue 10, 2013, Pages 943-946

  Belizna, C ^a,b   Subra, J F ^a   Henrion, D ^b   Ghali, A ^a   Renier, G ^a   Royer, M ^a   Corre, Y Le ^a   Martin, L ^a   Voswinkel, J ^c   Ifrah, N ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Malignancy; Myelodysplasia; Prognosis; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNITY; DISEASE ASSOCIATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPATHOLOGY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NATURAL KILLER CELL; PROGNOSIS; REGULATORY MECHANISM; REVIEW; SURVIVAL; SYSTEMIC VASCULITIS; VASCULITIS;

MALIGNANCY; MYELODYSPLASIA; PROGNOSIS; VASCULITIS;

HUMANS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SYSTEMIC VASCULITIS;

EID: 84880623303     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.01.005     Document Type: Review

References (65)

1. Greer J.M., Longley S., Edwards N.L., Elfenbein G.J., Panush R.S. Vasculitis associated with malignancy. Experience with 13 patients and literature review. Medicine 1988, 67:220-230.
2. Kurzock R., Cohen P.R. Vasculitis and cancer. Clin Dermatol 1993, 11:175-187.
3. Fain O., Hamidou M., Cacoub P., et al. Vasculitides associated with malignancies: analysis of 60 patients. Arthritis Rheum 2007, 57:1473-1480.
4. Fain O., Guillevin L., Kaplan G., et al. Vasculitis and neoplasms: 14 cases. Ann Intern Med 1991, 142:486-504.
5. Hutson T.E., Hoffman G.S. Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 2000, 13:417-423.
6. Solans-Laqué R., Bosch-Gil J.A., Pérez-Bocanegra C., et al. Paraneoplastic vasculitis in patients with solid tumors. Report of 15 cases. J Rheumatol 2008, 35:292-304.
7. Park H.J., Ranganathan P. Neoplastic and paraneoplastic vasculitis, vasculopathy, and hypercoagulability. Rheum Dis Clin North Am 2011, 37:593-606.
8. Naschitz J.E., Rosner I., Rozenbaum M., Elias N., Yeshurun D. Cancer-associated rheumatic disorders. Semin Arthritis Rheum 1995, 24:231-241.
9. Kurzrock R., Cohen P.R. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med 1995, 99:207-216.
10. Mufti G.J., Figes A., Hamblin T.J., Oscier D.J., Copplestone J.A. Immunological abnormalities in myelodysplastic syndromes. Br J Haematol 1986, 63:143-147.
11. Anderson L.A., Pfeiffer R.M., Landgren O., et al. Risk of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 2009, 100:822-828.
12. Dreyfus B., Vernant J.P., Wechsler J., Imbert M., De Prost Y., Reyes F., et al. Refractory anaemia with an excess of myeloblasts and cutaneous vasculitis. Nouv Rev Fr Hematol 1981, 23:115-121.
13. Saif M.W., Hopkins J.L., Gore S.D. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002, 43:2083-2092.
14. Enright H., Jacob H.S., Vercelotti G., et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995, 91:403-408.
15. Pirayesh A., Verbunt R.J.A.M., Kluin P.M., et al. Myelodysplastic syndrome with vasculitic manifestations. J Intern Med 1997, 242:425-431.
16. Liozon E., Loustaud V., Fauchais A.L., et al. Concurrent temporal (giant cell) arterites and malignancy: report of 20 patients with review of the literature. J Rheumatol 2006, 33:1606-1614.
17. Steurer M., Fritsch G., Tzankov A., et al. Large vessel arteritis and myelodysplastic syndrome: report of cases. Eur J Haematol 2004, 73:128-133. [e].
18. Cohen M.J., Shyman A., Klein M., et al. Large vessel (Takayasu's) arteritis in a patient with myelodysplastic syndrome: is there a common pathogenesis?. Clin Lymphoma Myeloma Leuk 2011, 11:60-63.
19. Park J.K., Gelber A.C., Zheng G., et al. Large vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia. J Clin Oncol 2011, 29:e601-e603.
20. Brickner L.A., Scannell K.A. Medium-vessel PAN-type vasculitis associated with myelodysplastic syndrome and presenting as bilateral perinephric hematomas. Clin Exp Rheumatol 1997, 15:221-222.
21. Warren A.J., Hegde U.M., Nathwani A., Reilly I.A.G. Systemic vasculitis and myelodysplasia. Br J Haematol 1990, 75:627-629.
22. Leung A.C., McLay A., Boulton-Jones J.M. Polyarteritis nodosa and monocytic leukaemia. Postgrad Med J 1986, 62:35-37.
23. van Rijn R.S., Wittebol S., Graafland A.D., Kramer M.H. Immunologic phenomena as the first sign of myelodysplastic syndrome. Ned Tijdschr Geneeskd 2001, 145:1529-1533.
24. Philippe B., Couderc L.J., Droz D., et al. Systemic vasculitis and myelodysplastic syndromes. A report of two cases. Arthritis Rheum 1997, 40:179-182.
25. Smail A., Ducroix J.P., Sahir R., et al. Wegener's disease and myelomonocytic leukemia: a fortuitous association?. Rev Med Interne 1989, 10:463-465.
26. Taillan B., Ferrari E., Garnier G., et al. Association of Wegener's disease and myelodysplastic syndrome. Ann Med Interne 1992, 143:478-479.
27. Constans J., Vidal E., Conri C., et al. Periarteritis nodosa and preleukemic states. Ann Med Interne 1992, 143:477-478.
28. Fernández-Miranda C., García-Marcilla A., Martín M., et al. Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases. Med Clin 1994, 103:539-542.
29. Oostvogels R., Petersen E.J., Chauffaille M.L., et al. Systemic vasculitis in myelodysplastic syndromes. Neth J Med 2012, 70:63-68.
30. Noel N., Butel N., Le Hoang P., Koskas F., Costedoat-Chalumeau N., Wechsler B., et al. Small vessel involvement in Takayasu's arteritis. Autoimmun Rev Jan 2013, 12:355-362.
31. Diebold L., Rauh G., Jager K., Lohrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br J Haematol 1995, 89:820-830.
32. Savige J.A., Chang L., Smith C.L., Duggan J.C. Myelodysplasia, vasculitis and anti-neutrophil cytoplasm antibodies. Leuk Lymphoma 1993, 9:49-54.
33. Giannouli S., Voulgarelis M., Zintzaras1 E., Tzioufas A.G., Moutsopoulos H.M. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology 2004, 43:626-632.
34. Sinico R.A., Meroni P. The kaleidoscopic manifestations of systemic vasculitis. Autoimmun Rev 2013, 12:459-462.
35. Aslangul-Castier E., Papo T., Amoura Z., Baud O., Leblond V., Charlotte F., et al. Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia. Ann Rheum Dis May 2000, 59:390-393.
36. Presti J.C., Carroll P.R. Bilateral spontaneous renal haemorrhage due to polyarteritis nodosa. West J Med 1991, 155:527-528.
37. Espinosa G., Font J., Muñoz-Rodríguez F.J., et al. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?. Clin Rheumatol 2002, 21:309-313.
38. Marzano A.V., Vezzoli P., Berti E. Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev 2013, 12:467-476.
39. Farrah C., Livideanu C.B., Jegu J., et al. Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome. JEADV 2010, 24:1171-1175.
40. Hamblin T. Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am 1992, 6:571-586.
41. Hamblin T.J. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 1996, 33:150-162.
42. Castro M., Conn D.L., Su W.P., Garton J.P. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991, 18:721-727.
43. Billstrom R., Johansson H., Johansson B., Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes- clinical and cytogenetic features. Eur J Haematol 1995, 55:42-48.
44. Hamidou M.A., Boumalassa A., Larroche C., et al. Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia. Semin Arthritis Rheum 2001, 31:119-126.
45. George S.W., Newman E.D. Seronegative inflammatory arthritis in the myelodysplastic syndromes. Semin Arthritis Rheum 1992, 21:345-354.
46. Hamidou M., Derenne S., Audrain M., Berthelot J.M., Boumalassa A., Grolleau J.Y. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. Rheumatology 2000, 39:417-420.
47. Radice A., Bianchi L., Sinico R.A. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 2013, 12:487-495.
48. Sinico R.A., Di Toma L., Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 2013, 12:477-482.
49. Okamoto T., Okada M., Mori A., et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 1997, 66:345-351.
50. Hollanda A., Beucher A., Henricoron D., et al. Systemic and immune manifestations in myelodysplasia. A multicenter retrospective study. Arthritis Care Res 2011, 63:1188-1194.
51. Heaney M.L., Golde D.W. Myelodysplasia. N Engl J Med 1999, 340:1649-1660.
52. Lopez F.F., Vaidyan P.B., Mega A.E., Schiffman F.J. Aortitis as a manifestation of myelodysplastic syndrome. Postgrad Med J 2001, 77:116-118.
53. Incalzi R.A., Arena V., Capelli A., Gambassi G. Isolated PACNS-like presentation of a systemic vasculitis complicating a myelodysplastic syndrome. J Intern Med 2004, 255:674-679.
54. Belizna C.C., Kerleau J.M., Heron F., et al. Vasculitis and myelodysplasia. Isr Med Assoc J 2008, 10:156-157.
55. Roy-Peaud F., Paccalin M., Le Moal G., et al. Association of systemic diseases and myelodysplastic syndromes. A retrospective study of 14 cases. Presse Med 2003, 32:538-543.
56. Berthier S., Magy N., Gil H., et al. Myelodysplasias and systemic diseases. A non-fortuitous association. Rev Med Interne 2001, 22:428-432.
57. Shetty V., Allampallam K., Raza A. Increased macrophages, high serum M-CSF and low serum cholesterol in myelodysplasia and Kawasaki disease. Br J Haematol 1999, 106:1068-1070.
58. Voulgarelis M., Giannouli S., Ritis K., Tzioufas A.G. Myelodysplasia associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 2004, 34:690-700.
59. Williamson P.J., Oscier D.G., Bell A.J., Hamblin T.J. Red cell aplasia in myelodysplastic syndrome. J Clin Pathol 1991, 44:431-432.
60. Giannouli S., Tzoanopoulos D., Ritis K., et al. Autoimmune manifestations in human myelodysplasia. A positive correlation with Interferon regulatory factor-1 (IRF-1) expression. Ann Rheum Dis 2004, 63:578-582.
61. Kroger A., Koster M., Schroeder K., Hauser H., Mueller P.P. Activities of IRF-1. J Interferon Cytokine Res 2002, 22:5-14.
62. Coll-Vinent B., Cebrian M., Cid M.C., et al. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 1998, 41:435-444.
63. Cid M.C., Cebrian M., Font C., et al. Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions. Arthritis Rheum 2000, 43:184-194.
64. Giannouli S., Kanellopoulou T., Voulgarelis M. Myelodysplasia and autoimmunity. Curr Opin Rheumatol 2012, 24:97-102.
65. Mavropoulos A., Orfanidou T., Liaskos C., Smyk D.S., Billinis C., Blank M., et al. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmun Rev 2013, 12:580-590.